FDA Approves Tapentadol Immediate-Release Tablets For Relief Of Moderate To Severe Acute Pain Millions of Americans with moderate to severe acute pain and their
health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older. Tapentadol is a new centrally acting oral analgesic.
Source: www.medicalnewstoday.comNew Journal Emphasizes Principles Of Injury, Function And Rehabilitation Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce the January 2009 launch of a new medical journal in partnership with the American Academy of Physical
Medicine and Rehabilitation -- PM&R, The journal of injury, function and rehabilitation (http://www.pmrjournal.org). Under the guidance of Editor-in-Chief Stuart M.
Source: www.medicalnewstoday.com
# posted by Network @ 2:00 PM
